Essential Elements of Technology Transfer

The lifecycle of pharmaceutical development always requires the transfer of the production process and analytical methods from development into Good Manufacturing Practices (GMP) manufacturing and quality control laboratories.

This transfer can take many forms. Traditional pharmaceutical organizations usually have full in-house product development and manufacturing capability, whereas small startup organizations leverage contract development and manufacturing organizations (CDMOs) to bring their discoveries from the research bench to human clinical trials.

Regardless of the nature and maturity of the organization, an effective technology transfer program is essential to the success of pharmaceutical development.

Published on:
September 21, 2023
Peter Alexander

Our own Peter Alexander, Senior Consultant, Chemistry, Manufacturing & Controls (CMC), co-authored an article entitled “Essential Elements Of Technology Transfer” that dives into technology transfer categories, essential elements, documentation, and much more.

The article is available on “Bioprocess Online.”

Contact us to discover how our team’s comprehensive knowledge in biologics and ADCs can make a significant difference in your development journey.

Related news

Publications November 20, 2023
Therapeutic IgG-Like Bispecific Antibodies: Modular Versatility and Manufacturing Challenges
Our experts conducted a deep evaluation of IgG-like bsAbs including general advantages and disadvantages compared with MAbs and more.
Publications November 20, 2023
Immunoglobulin Fc-Fusion Proteins
Our experts published a series of articles in BioProcess International reviewing the state of the art of Fc – fusion proteins, including their structure and molecular design, manufacturing(...)
Publications November 14, 2023
Capture of CH1-Containing Bispecific Antibodies: Evaluating an Alternative to Protein A
In the article our team investigated the use of an alternative purification method for BsAbs – a commercially available CaptureSelect CH1-XL affinity resin.
CMC Drug Development
Multimedia October 18, 2023
The Process of CDMO Selection for Antibody Development: Matching Capabilities to Need
In this webinar, you'll learn how to identify key solution features, define patient experience expectations, generate evidence, and more!
Events September 27, 2023
Advances in Biologics and CGT
We are excited to share that we will be joining the Networking Reception: Advances in Biologics and CGT hosted by Catalent.
Biologics CMC
Publications September 21, 2023
Essential Elements of Technology Transfer
Peter Alexander, Senior Consultant, CMC, co-authored an article about technology transfer categories, essential elements, and documentation.
Publications September 20, 2023
Manufacturing Challenges of Therapeutic Antibody-Drug Conjugates
Our expert CMC team addresses the manufacturing challenges of ADCs in “Manufacturing Challenges of Therapeutic Antibody-Drug Conjugates.”
CMC Drug Development
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.